Aim: Describe the control of cardiovascular risk factors (CVRF) in patients with diabetes and myocardial infarction (MI) as well as their treatment and control.
Patients and methods: Observational retrospective study of a cohort of patients with diabetes admitted to the cardiology department because of a MI between November 2015 and November 2016. Statistical analysis performed with SPSS 24th version.
Results: 421 patients admitted because of a MI. 140 patients (33.4%) with diabetes (DM) prior to admission. 97.8% with type 2 DM. 8 patients (5.7%) diagnosed with DM during their stay. 65% of the diabetic patients received oral hypoglycemic agents (OHAs), 15.7% insulin and 15% OHAs + Insulin. 5 patients didnt receive pharmacological treatment. HbA1c test was ordered in 57.7% of these patients and 40.5% of them had a good glycemic control, with a HbA1c below 7%. Lipid panel was ordered in 70.5% of patients and 64.8% of them had LDL levels below 100 mg/dL. Smoking status was assessed in 51.7% of the patients: 42.9% were smokers and 31.2% were quitters. One year after the event 25.5% of patients had dead. Lipid panel was being followed in 79.2% of patients and 50.9% met their LDL target (below 70 mg/dL). There had been a statistically significant LDL reduction in these patients. Smoking status was asked in 51.9% of the patients and 60.9% of smokers had quitted, being the proportion of quitters statistically significant. In 81.13% patients HbA1c was being assessed and 36.8% of patients met their HbA1c target (below 7%). HbA1c was lower but the reduction was not statistically significant.
Conclusions: 1. CVRF are assessed in most patients with diabetes admitted because of a MI being lipid panel the most ordered (70.5%) in comparison to HbA1c (57.7%) and smoking status (51.7%)
2. Most diabetic patients that suffer myocardial infarction do not meet their glycemic target (59.5%).
3. In our series there is a statistically significant reduction in LDL levels and in the proportion of smokers. HbA1c is also improved but the reduction is not statistically significant.
18 - 21 May 2019
European Society of Endocrinology